Oxford Global Conferences, Hilton San Diego Bayfront, 1 Park Blvd, CA 92101
12th-13th October 2023
Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
Expand your knowledge & discuss future priorities in:
- Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology
- Discovery & Development: Intra-tumoral Immuno & Combination Therapies & Small Molecules as IO Therapies
- Translational & Preclinical and Clinical Development
View the agenda here - https://www.oxfordglobal.co.uk/immuno-series-us/agenda/?utm_source=hummolgen&utm_medium=eventlisting&utm_campaign=immuno&utm_content=immunous2023
Co-located with Biomarkers US 2023 attendees receive access to both events. For more information contact marketing@oxfordglobal.co.uk
Organized by:
Oxford Global Conferences
Invited Speakers:
The 2023 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Meet key decision makers representing large pharma & biotech companies:
Thomas Schurp - Vice President, PRTH-101 and Protein Sciences, Partheon Therapeutics